MedTrace Logo

Effects of Kinesio Taping Versus McConnell Taping on Clinical Outcomes in Patients With Patellofemoral Pain Syndrome.

NCT07671482 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-06-26

No results posted yet for this study

Summary

The primary goal of this randomized clinical trial (RCT) is to evaluate whether Kinesio Taping versus McConnell Taping, when integrated into a standardized hip-knee strengthening and neuromuscular control program, produces significant effects in individuals aged 18-50 with patellofemoral pain syndrome (PFPS).

The main question it aims to answer is: Does Kinesio Taping compared with McConnell Taping when both combined with a standardized hip-knee exercise program, produce different effects on quadriceps neuromuscular activation (VMO-VL sEMG), pain, functional knee pain, and dynamic knee valgus over a 6 week period intervention?

Participants will be divided into three groups for comparison: the control group will receive a structured hip-knee physical therapy exercise program without any taping intervention, Kinesio Taping group with a standardized exercise program, and a McConnell Taping group with a standardized exercise program.

Conditions

  • Patello Femoral Pain Syndrome
  • Anterior Knee Pain Syndrome
  • PFPS
  • Patellofemoral Pain Syndrome
  • Patellofemoral Disorder
  • Patellofemoral Pain, PFP
  • Patellofemoral Pain (PFPS)

Interventions

OTHER

Kinesio Taping

Kinesio Taping will be applied to the patellofemoral joint during a 6-week structured hip-knee exercise program.

OTHER

McConnell Taping

McConnell Taping will be applied to correct patellar alignment during a 6-week structured hip-knee exercise program.

OTHER

Exercise Therapy

A standardized hip-knee strengthening and neuromotor training program will be performed for 6 weeks.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmed El Melhat, PhD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2026-09-30
Completion
2026-10-31

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07671482 on ClinicalTrials.gov